IRIS

Personal experience with the use of betamethasone, used orally in associated with various cytostatic drugs for inducing remission in acute lymphatic leucosis and some cases of lymphoproliferative disease is reported. The results obtained point to the effectiveness and tolerance of the drug, even in the high doses that are required to treat such blood diseases.

[Betamethasone in the treatment of acute lymphatic leukosis and other lymphoproliferative diseases].

INVERNIZZI, ROSANGELA
1980-01-01

Abstract

Personal experience with the use of betamethasone, used orally in associated with various cytostatic drugs for inducing remission in acute lymphatic leucosis and some cases of lymphoproliferative disease is reported. The results obtained point to the effectiveness and tolerance of the drug, even in the high doses that are required to treat such blood diseases.
1980
Medical Research, Diagnosis & Treatment contains studies of existing and developing diagnostic and therapeutic techniques, as well as specific classes of clinical intervention. Resources in this category emphasize the difference between normal and disease states, with the ultimate goal of more effective diagnosis and intervention. Specific areas of interest include pathology and histochemical analysis of tissue, clinical chemistry and biochemical analysis of medical samples, diagnostic imaging, radiology and radiation, surgical research, anesthesiology and anesthesia, transplantation, artificial tissues, and medical implants. Resources focused on the disease, diagnosis, and treatment of specific organs or physiological systems are excluded and are covered in the Medical Research: Organs & Systems category.
MINERVA MEDICA
sì
Sì, ma tipo non specificato
Italiano
Nazionale
STAMPA
71
3247
3250
4
6935535
Betamethasone; Treatment; Acute lymphoblastic leukemia
1
info:eu-repo/semantics/article
262
Invernizzi, Rosangela
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/557261
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact